Cas 1973-03-1,4-chloro-N-methyl-6-phenyl-1,3,5-triazin-2-amine

1973-03-1

Post Buying Request

Basic information

Product Name: 4-chloro-N-methyl-6-phenyl-1,3,5-triazin-2-amine
Synonyms:
CAS NO:1973-03-1
Molecular Formula: C₁₀H₉ClN₄
Molecular Weight: 220.6583
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: 420.9°C at 760 mmHg
Flash Point: 208.3°C
Appearance: N/A
Density: 1.33g/cm³
Vapor Pressure: 2.72E-07mmHg at 25°C
Refractive Index: 1.638
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-chloro-N-methyl-6-phenyl-1,3,5-triazin-2-amine(CAS DataBase Reference)
NIST Chemistry Reference: 4-chloro-N-methyl-6-phenyl-1,3,5-triazin-2-amine(1973-03-1)
EPA Substance Registry System: 4-chloro-N-methyl-6-phenyl-1,3,5-triazin-2-amine(1973-03-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1973-03-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1973-03-1 Suppliers

Recommended suppliers

1973-03-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1973-03-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,7 and 3 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1973-03:
(6*1)+(5*9)+(4*7)+(3*3)+(2*0)+(1*3)=91
91 % 10 = 1
So 1973-03-1 is a valid CAS Registry Number.

1973-03-1Upstream product

1973-03-1Downstream Products

1973-03-1Relevant academic research and scientific papers

NOVEL SEH INHIBITORS AND THEIR USE

-

Page/Page column 59, (2009/05/28)

The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH enzyme. Specifically, the invention is directed to compounds according to Formula I: (I) wherein R1, R2, R3, R5a, R6a A, B, Y, x, and m are defined below, and to pharmaceutically-acceptable salts thereof. The compounds of the invention are sEH inhibitors and can be used in the treatment of diseases mediated by the sEH enzyme, such as hypertension. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting sEH and treatment of conditions associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

NOVEL SEH INHIBITORS AND THEIR USE

-

Page/Page column 40, (2009/05/28)

The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH enzyme. Specifically, the invention is directed to compounds according to Formula I: wherein R1, R2, R4, R5, R6, A, B, Y, Z, n, and m are defined below, and to pharmaceutically-acceptable salts thereof. The compounds of the invention are sEH inhibitors and can be used in the treatment of diseases mediated by the sEH enzyme, such as hypertension. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting sEH and treatment of conditions associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1973-03-1